Aligos Therapeutics annual operating margin
2023
2024
2025
Aligos Therapeutics Operating Margin Growth & History (ALGS)
Aligos Therapeutics's operating margin was −4,024.93% for fiscal 2025.
View full Aligos Therapeutics company overviewAligos Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −4,024.93% | −1555.98 pp |
| 2024 | 2024-12-31 | −2,468.96% | −1045.49 pp |
| 2023 | 2023-12-31 | −1,423.47% | — |
Aligos Therapeutics quarterly operating margin
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −951.55% | +5235.91 pp |
| Q4 2025 | 2025-12-31 | −12,907.69% | −9514.46 pp |
| Q3 2025 | 2025-09-30 | −3,827.40% | −2216.92 pp |
| Q2 2025 | 2025-06-30 | −1,924.04% | +565.50 pp |
| Q1 2025 | 2025-03-31 | −6,187.46% | −3010.80 pp |
| Q4 2024 | 2024-12-31 | −3,393.23% | +475.37 pp |
| Q3 2024 | 2024-09-30 | −1,610.48% | +147.22 pp |
| Q2 2024 | 2024-06-30 | −2,489.54% | −2043.78 pp |
| Q1 2024 | 2024-03-31 | −3,176.66% | +13907.63 pp |
| Q4 2023 | 2023-12-31 | −3,868.60% | — |
| Q3 2023 | 2023-09-30 | −1,757.70% | — |
| Q2 2023 | 2023-06-30 | −445.76% | — |
| Q1 2023 | 2023-03-31 | −17,084.29% | — |
Aligos Therapeutics operating margin trends
Across the available reported history, Aligos Therapeutics's operating margin decreased from −2,468.96% to −4,024.93%, a change of −1555.98 percentage points. The latest reported quarter, Q1 2026, shows −951.55%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aligos Therapeutics filings at SEC.gov ↗